Amid the vaping “epidemic,” Congress has begun its own investigation into the marketing practices and popularity of JUUL. On July 25, 2019, a House Oversight and Government Reform subcommittee on Capitol Hill held a hearing on the youth epidemic where they required James Monsees, JUUL Labs co-founder, to testify on the role his company has had in the youth vaping craze.
During the hearing, Monsees told members of the committee that “JUUL Labs isn’t big tobacco” and that JUUL was never intended for teenagers. Monsees went on to say that the aim of JUUL from the start has been to “eliminate cigarettes for good.” Monsees developed as a graduate student JUUL with a fellow Stanford design student, Adam Bowen. Since its launch, JUUL has become the most popular e-cigarette in the U.S., but its rise to the top has come with much scrutiny and accusations that it has also contributing to the increasing number of teenagers who are vaping. Though some vape companies have claimed that vaping is a safer alternative to traditional combustible tobacco products, many of these claims have not fully been studied and verified as many e-cigarettes, including JUUL, have yet to be fully studied by or approved by the U.S. Food and Drug Administration (FDA),
Continue Reading On: Tobacco Business Magazine